6月2日，Medline Inc盘中下跌5.03%，报33.95美元/股，成交额2.01亿美元。
消息面上，公司于6月1日披露12笔内部人交易，持股10%以上股东BCP 8 Holdings Mozart Manager等机构于5月28日合计卖出9850.39万股，成交均价36.54美元，总金额约35.99亿美元。此外，公司此前刚于5月29日完成一笔7260万股的二次发行，定价37.00美元/股，且承销商另获30天超额配售权最多约1090万股。短期内大规模解禁减持叠加二次发行集中放量，显著增加市场流通供给，对股价形成持续抛压。
Medline Inc.是医疗外科产品和供应链解决方案的最大供应商，提供手术套件、手套防护服、伤口护理等关键产品，服务于医院、手术中心及急症后设施等多种护理场景。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.